I checked the UCB home page and investor site (http://www.ucb.com/investors/), no news about today's PR from IMMU, why UCB is not trumpeting the study results as they will make more money from lupus drug, no bashing please, please give some good answers
Hgsi is a treatment for mild to moderate Lupus and was only slightly better than using advil. It only achieved statistical results by increasing steroid levels (which you should try to decrease)in patients and was only statistically affective after using the treatment for a year. It was then not statistically affective after that point. So if you want to pay $10,000 or more a year and increase steroid use and have results at a year and then have decreased results after that then HGSI would be your treatment choice.